曾彥寒

https://orcid.org/0000-0002-7504-0678

電子郵件18000@s.tmu.edu.tw

來源：Scopus
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。

每年研究成果

如果您對這些純文本內容做了任何改變，很快就會看到。

個人檔案

學歷

2013-2015 國立陽明大學醫學院急重症醫學研究所碩士
2000-2007 長庚大學醫學系學士

經歷

衛生福利部雙和醫院主治醫師
2020.10- 臺北醫學大學醫學系內科學科助理教授
2009.08-2017.12 臺北榮民總醫院主治醫師

指紋

查看啟用 Yen-Han Tseng 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。

9 類似的個人檔案

網路

國家層面的近期外部共同作業。通過按一下圓點深入探索詳細資料。

119 引文
7 h-指數
14 文章
2 快報
1 評論/辯論

Efficacy of paclitaxel plus TS1 against previously treated EGFR mutated non-small cell lung cancer
Tseng, Y. H., Shih, J. F., Chao, H. S. & Chen, Y. M., 一月 1 2019, 於: PeerJ. 2019, 9, e7767.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
Prognostic factors and first-line treatment modalities in nonagenarian patients with lung cancer
Hsu, C. C., Huang, Y. T., Tseng, Y. H., Luo, Y. H. & Chen, Y. M., 五月 1 2019, 於: Journal of Geriatric Oncology. 10, 3, p. 439-441 3 p.
研究成果: 雜誌貢獻 › 快報 › 同行評審
A new application for argon beam coagulation: The thymoma patient with pleural recurrence
Tseng, Y. C., Tseng, Y. H., Tang, E. K. & Goan, Y. G., 五月 1 2018, 於: Journal of Thoracic Disease. 10, 5, p. E355-E358
研究成果: 雜誌貢獻 › 文章 › 同行評審
3 引文斯高帕斯（Scopus）
PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non–Small Cell Lung Cancer Patients with Malignant Pleural Effusion
Tseng, Y. H., Ho, H. L., Lai, C. R., Luo, Y. H., Tseng, Y. C., Whang-Peng, J., Lin, Y. H., Chou, T. Y. & Chen, Y. M., 三月 1 2018, 於: Journal of Thoracic Oncology. 13, 3, p. 447-453 7 p.
研究成果: 雜誌貢獻 › 文章 › 同行評審
18 引文斯高帕斯（Scopus）
Erratum: Correction: Long term oncological outcome of thymoma and thymic carcinoma - an analysis of 235 cases from a single institution (PloS one (2017) 12 6 (e0179527))
Tseng, Y. C., Tseng, Y. H., Kao, H. L., Hsieh, C. C., Chou, T. Y., Goan, Y. G., Hsu, W. H. & Hsu, H. S., 一月 1 2017, 於: PLoS ONE. 12, 9, p. e0185399 e0185399.
研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

Data for: Prognostic factors and first-line treatment modalities in nonagenarian patients with lung cancer
Chen, Y. (Contributor), Huang, Y. (Contributor), Tseng, Y. (Contributor), Luo, Y. H. (Contributor) & Hsu, C. (Contributor), Unknown Publisher, 十二月 24 2018
DOI: 10.17632/mt59dnxm3h.1, https://data.mendeley.com/datasets/mt59dnxm3h
資料集: Dataset

學歷

經歷

Efficacy of paclitaxel plus TS1 against previously treated EGFR mutated non-small cell lung cancer

Prognostic factors and first-line treatment modalities in nonagenarian patients with lung cancer

A new application for argon beam coagulation: The thymoma patient with pleural recurrence

PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non–Small Cell Lung Cancer Patients with Malignant Pleural Effusion

Erratum: Correction: Long term oncological outcome of thymoma and thymic carcinoma - an analysis of 235 cases from a single institution (PloS one (2017) 12 6 (e0179527))

Data for: Prognostic factors and first-line treatment modalities in nonagenarian patients with lung cancer